amphotericin-b and Jaw-Diseases

amphotericin-b has been researched along with Jaw-Diseases* in 2 studies

Other Studies

2 other study(ies) available for amphotericin-b and Jaw-Diseases

ArticleYear
Association of topical amphotericin B lipid complex treatment to standard therapy for rhinomaxillary mucormycosis after liver transplantation: a case report.
    Transplantation proceedings, 2012, Volume: 44, Issue:7

    Solid organ transplantation is becoming increasingly more common in the treatment of end-stage organ failure. The advent of newer immunosuppressive protocols and refined surgical techniques has allowed therapy to become standard care. Infection is a major and frequently life-threatening complication after transplantation and the incidence of opportunistic fungal infections in organ transplant recipients ranges from 2%-50% depending on the type of organ transplanted. We present a case of rhinomaxillary form of mucormycosis infection after liver transplantation. The succession of multiple risk factors in a torpid postoperative period was a key factor in the development of this disease. Multidisciplinary management with an early diagnosis, aggressive surgery, and intravenous and topical antifungal therapy care were definitive for the eradication of infection. The goal of the present report was to show efficacious management including the association of topical treatment with amphotericin B complex lipid to standard therapy and the absence of side effects.

    Topics: Administration, Topical; Amphotericin B; Humans; Jaw Diseases; Male; Middle Aged; Mucormycosis; Nose Diseases

2012
Sequestration of the alveolar bone by invasive aspergillosis in acute myeloid leukemia.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1997, Volume: 26, Issue:9

    Compared to non-invasive aspergillosis, invasive aspergillosis in the region of the mouth, jaw and face has rarely been reported. It occurs particularly often in the presence of haematological oncological illness. The case of a patient suffering from acute myeloid leukemia is described; he contracted invasive aspergillosis of the lungs and the alveolar processes in the course of chemotherapeutic treatment. All the alveolar processes in the region of the premolars and molars were demarcated and had to be removed by sequestrectomy. The therapy of invasive aspergillosis should be carried out within the framework of intensive interdisciplinary treatment. In addition to systemic and local antimycotic therapy, the debridement of necrotic hard and soft tissue was necessary.

    Topics: Acute Disease; Adult; Alveolar Process; Alveolectomy; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Humans; Jaw Diseases; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Osteonecrosis

1997